207 related articles for article (PubMed ID: 35377426)
1. Association of Genetic Variants Linked to Late-Onset Alzheimer Disease With Cognitive Test Performance by Midlife.
Zimmerman SC; Brenowitz WD; Calmasini C; Ackley SF; Graff RE; Asiimwe SB; Staffaroni AM; Hoffmann TJ; Glymour MM
JAMA Netw Open; 2022 Apr; 5(4):e225491. PubMed ID: 35377426
[TBL] [Abstract][Full Text] [Related]
2. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.
Jansen WJ; Ossenkoppele R; Tijms BM; Fagan AM; Hansson O; Klunk WE; van der Flier WM; Villemagne VL; Frisoni GB; Fleisher AS; Lleó A; Mintun MA; Wallin A; Engelborghs S; Na DL; Chételat G; Molinuevo JL; Landau SM; Mattsson N; Kornhuber J; Sabri O; Rowe CC; Parnetti L; Popp J; Fladby T; Jagust WJ; Aalten P; Lee DY; Vandenberghe R; Resende de Oliveira C; Kapaki E; Froelich L; Ivanoiu A; Gabryelewicz T; Verbeek MM; Sanchez-Juan P; Hildebrandt H; Camus V; Zboch M; Brooks DJ; Drzezga A; Rinne JO; Newberg A; de Mendonça A; Sarazin M; Rabinovici GD; Madsen K; Kramberger MG; Nordberg A; Mok V; Mroczko B; Wolk DA; Meyer PT; Tsolaki M; Scheltens P; Verhey FRJ; Visser PJ; ; Aarsland D; Alcolea D; Alexander M; Almdahl IS; Arnold SE; Baldeiras I; Barthel H; van Berckel BNM; Blennow K; van Buchem MA; Cavedo E; Chen K; Chipi E; Cohen AD; Förster S; Fortea J; Frederiksen KS; Freund-Levi Y; Gkatzima O; Gordon MF; Grimmer T; Hampel H; Hausner L; Hellwig S; Herukka SK; Johannsen P; Klimkowicz-Mrowiec A; Köhler S; Koglin N; van Laere K; de Leon M; Lisetti V; Maier W; Marcusson J; Meulenbroek O; Møllergård HM; Morris JC; Nordlund A; Novak GP; Paraskevas GP; Perera G; Peters O; Ramakers IHGB; Rami L; Rodríguez-Rodríguez E; Roe CM; Rot U; Rüther E; Santana I; Schröder J; Seo SW; Soininen H; Spiru L; Stomrud E; Struyfs H; Teunissen CE; Vos SJB; van Waalwijk van Doorn LJC; Waldemar G; Wallin ÅK; Wiltfang J; Zetterberg H
JAMA Psychiatry; 2018 Jan; 75(1):84-95. PubMed ID: 29188296
[TBL] [Abstract][Full Text] [Related]
3. Association of genetic risk for Alzheimer disease and hearing impairment.
Brenowitz WD; Filshtein TJ; Yaffe K; Walter S; Ackley SF; Hoffmann TJ; Jorgenson E; Whitmer RA; Glymour MM
Neurology; 2020 Oct; 95(16):e2225-e2234. PubMed ID: 32878991
[TBL] [Abstract][Full Text] [Related]
4. Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.
Nho K; Kueider-Paisley A; Ahmad S; MahmoudianDehkordi S; Arnold M; Risacher SL; Louie G; Blach C; Baillie R; Han X; Kastenmüller G; Trojanowski JQ; Shaw LM; Weiner MW; Doraiswamy PM; van Duijn C; Saykin AJ; Kaddurah-Daouk R;
JAMA Netw Open; 2019 Jul; 2(7):e197978. PubMed ID: 31365104
[TBL] [Abstract][Full Text] [Related]
5. Extension of Mendelian Randomization to Identify Earliest Manifestations of Alzheimer Disease: Association of Genetic Risk Score for Alzheimer Disease With Lower Body Mass Index by Age 50 Years.
Brenowitz WD; Zimmerman SC; Filshtein TJ; Yaffe K; Walter S; Hoffmann TJ; Jorgenson E; Whitmer RA; Glymour MM
Am J Epidemiol; 2021 Oct; 190(10):2163-2171. PubMed ID: 33843952
[TBL] [Abstract][Full Text] [Related]
6. Association of Cognitive Function Trajectories in Centenarians With Postmortem Neuropathology, Physical Health, and Other Risk Factors for Cognitive Decline.
Beker N; Ganz A; Hulsman M; Klausch T; Schmand BA; Scheltens P; Sikkes SAM; Holstege H
JAMA Netw Open; 2021 Jan; 4(1):e2031654. PubMed ID: 33449094
[TBL] [Abstract][Full Text] [Related]
7. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.
Donohue MC; Sperling RA; Salmon DP; Rentz DM; Raman R; Thomas RG; Weiner M; Aisen PS; ; ;
JAMA Neurol; 2014 Aug; 71(8):961-70. PubMed ID: 24886908
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants associated with risk of Alzheimer's disease contribute to cognitive change in midlife: The Atherosclerosis Risk in Communities Study.
Bressler J; Mosley TH; Penman A; Gottesman RF; Windham BG; Knopman DS; Wruck LM; Boerwinkle E
Am J Med Genet B Neuropsychiatr Genet; 2017 Apr; 174(3):269-282. PubMed ID: 27781389
[TBL] [Abstract][Full Text] [Related]
9. Cognitive Function in People With Familial Risk of Depression.
Cullen B; Gameroff MJ; Ward J; Bailey MES; Lyall DM; Lyall LM; MacSweeney N; Murphy E; Sangha N; Shen X; Strawbridge RJ; van Dijk MT; Zhu X; Smith DJ; Talati A; Whalley HC; Cavanagh J; Weissman MM
JAMA Psychiatry; 2023 Jun; 80(6):610-620. PubMed ID: 37074691
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.
Tarawneh R; D'Angelo G; Crimmins D; Herries E; Griest T; Fagan AM; Zipfel GJ; Ladenson JH; Morris JC; Holtzman DM
JAMA Neurol; 2016 May; 73(5):561-71. PubMed ID: 27018940
[TBL] [Abstract][Full Text] [Related]
11. White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease.
Burns JM; Church JA; Johnson DK; Xiong C; Marcus D; Fotenos AF; Snyder AZ; Morris JC; Buckner RL
Arch Neurol; 2005 Dec; 62(12):1870-6. PubMed ID: 16344345
[TBL] [Abstract][Full Text] [Related]
12. Attention and executive control predict Alzheimer disease in late life: results from the Berlin Aging Study (BASE).
Rapp MA; Reischies FM
Am J Geriatr Psychiatry; 2005 Feb; 13(2):134-41. PubMed ID: 15703322
[TBL] [Abstract][Full Text] [Related]
13. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
14. Long-term Changes in Cognitive Functioning in Individuals With Psychotic Disorders: Findings From the Suffolk County Mental Health Project.
Fett AJ; Velthorst E; Reichenberg A; Ruggero CJ; Callahan JL; Fochtmann LJ; Carlson GA; Perlman G; Bromet EJ; Kotov R
JAMA Psychiatry; 2020 Apr; 77(4):387-396. PubMed ID: 31825511
[TBL] [Abstract][Full Text] [Related]
15. A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 Carriers.
Sapkota S; Dixon RA
J Alzheimers Dis; 2018; 62(2):887-900. PubMed ID: 29480189
[TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
17. Relationships between behavioral syndromes and cognitive domains in Alzheimer disease: the impact of mood and psychosis.
Koppel J; Goldberg TE; Gordon ML; Huey E; Davies P; Keehlisen L; Huet S; Christen E; Greenwald BS
Am J Geriatr Psychiatry; 2012 Nov; 20(11):994-1000. PubMed ID: 22048323
[TBL] [Abstract][Full Text] [Related]
18. Seasonal plasticity of cognition and related biological measures in adults with and without Alzheimer disease: Analysis of multiple cohorts.
Lim ASP; Gaiteri C; Yu L; Sohail S; Swardfager W; Tasaki S; Schneider JA; Paquet C; Stuss DT; Masellis M; Black SE; Hugon J; Buchman AS; Barnes LL; Bennett DA; De Jager PL
PLoS Med; 2018 Sep; 15(9):e1002647. PubMed ID: 30180184
[TBL] [Abstract][Full Text] [Related]
19. Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals.
Sperling RA; Donohue MC; Raman R; Sun CK; Yaari R; Holdridge K; Siemers E; Johnson KA; Aisen PS;
JAMA Neurol; 2020 Jun; 77(6):735-745. PubMed ID: 32250387
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's Disease Polygenic Scores Predict Changes in Episodic Memory and Executive Function Across 12 Years in Late Middle Age.
Gustavson DE; Reynolds CA; Hohman TJ; Jefferson AL; Elman JA; Panizzon MS; Neale MC; Logue MW; Lyons MJ; Franz CE; Kremen WS
J Int Neuropsychol Soc; 2023 Feb; 29(2):136-147. PubMed ID: 35184795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
